Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:56 PM
Ignite Modification Date:
2025-12-24 @ 10:56 PM
NCT ID:
NCT02666469
Eligibility Criteria:
Inclusion Criteria:
* age \> 18 years
* history of ischemic or hemorrhagic stroke 6-48 months confirmed by CT
* arm hemiparesis/hemiplegia
* Chedoke-McMaster Stroke Assessment Scale 3-6
* ability to follow verbal commands
Exclusion Criteria:
* women with positive pregnancy test or plans to become pregnant during the study period
* severe cognitive dysfunction (The Mini Mental State Examination \<24 )
* claustrophobia
* seizure disorder
* active asthma
* severe chronic obstructive pulmonary disease
* history of spontaneous pneumothorax
* history of severe congestive heart failure with left ventricular ejection fraction \< 30%; unstable angina
* myocardial infarction (within the last 3 months)
* chronic sinusitis
* chronic acute otitis media or major ear drum trauma
* current treatment with bleomycin, cisplatin, doxorubicin and disulfiram
* participation in another investigative drug or device trial currently or within the last 30 days
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT02666469
Study Brief:
Protocol Section:
NCT02666469